bpc 157 dosage protocols bpc-157 dosing protocol human BPC-157 Dosing (Common Protocols) πΉ Oral / Subcutaneous β’ 500 mcg daily β’ Duration: 6 weeks πΉ Intramuscular / Peritendinous β’ 1 mg daily β’ Duration: 6 weeks β οΈ Note: Not approved BPC 157: Science-Backed Uses, Benefits,
Description
Full documentation is available on request

ConsumerLab.com's answer explains

Each vial contains USP-grade water with 0.9% benzyl alcohol, a preservative that prevents bacterial growth and allows for multi-use over time

Our product provides a sterile, non-pyrogenic solution for your needs

Professional vial presentation and packaging

The practical difference for most people is minimal, though methylcobalamin skips the conversion step and may be preferable for individuals with certain genetic variations affecting B12 metabolism
